Jenny Fong

How GlaxoSmithKline is Accelerating Science with Docker Enterprise Edition

GlaxoSmithKline is a global pharmaceutical company headquartered in the United Kingdom. Their company mission is “to help people do more, feel better, and live longer”. One way they are doing that is by using data science to find new drug formulations that can improve lives. At DockerCon Europe, Ranjith Raghunath, the director of Big Data Solutions and Lindsay Edwards, the head of Respiratory Data Sciences at GlaxoSmithKline presented how Docker Enterprise Edition (Docker EE) is helping them accelerate drug discovery through a project called Edge Node On Demand. Letting Science Drive Technology at GlaxoSmithKline Leveraging Data Science for Improved Outcomes The biggest challenge in pharmaceutical research is that hundreds of drugs formulations need to be created to take one successfully to market only 3% of formulated molecules actually become medicine. Lindsay Edwards heads a Data Science group that is focused on respiratory illnesses like Continue reading…